PhRMA Continues Call For Downgrade In Thai Trade Status
This article was originally published in PharmAsia News
SHANGHAI - Once again the U.S. pharmaceutical industry has requested the U.S. government to downgrade Thailand's trade status due to intellectual property rights violations. The downgrade would subject Thai exports to higher tariffs and a loss of tax privileges in the U.S
You may also be interested in...
Sanofi-Aventis sent a request to the previous Thai Minister of Commerce Mingkwan Sangsuwan to review the process of compulsory licensing on patented drugs, Graham Almond, Sanofi-Aventis Thailand general manager told PharmAsia News.
SAN DIEGO - Industry furor over Thailand's compulsory license position will not deter multinational companies from investing in the country, according to Thai officials who sat down with PharmAsia News during the BIO 2008 convention in San Diego
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).